U.S. RESEARCH ROUNDUP-BlackRock, Emerson, Infosys

Origin Materials

14/10/2022 08:43

Oct 14 (Reuters) - Wall Street securities analysts revised their ratings and price targets on
several U.S.-listed companies, including BlackRock, Emerson and Infosys on Friday. 
  HIGHLIGHTS        
     * BlackRock Inc  BLK.N : JP Morgan cuts target price to $666 from $716
     * Emerson  EMR.N : Oppenheimer cuts target price to $105 from $110
     * Figs Inc  FIGS.N : Barclays cuts to equal weight from overweight
     * Infosys Ltd  INFY.N : Jefferies cuts target price to $20.8 from $21.3
 Following is a summary of research actions on U.S. companies reported by Reuters on Friday. Stock
entries are in alphabetical order.      
     * A O Smith Corp  AOS.N : Stifel cuts target price to $54 from $56
     * Applovin Corp  APP.O : Wedbush initiates with outperform rating; price target $26
     * Aptinyx Inc  APTX.O : SVB Securities cuts target price to $2 from $3
     * Axsome Therapeutics Inc  AXSM.O : SVB Securities cuts target price to $65 from $75
     * Berkshire Hills Bancorp Inc  BHLB.N : Piper Sandler cuts target price to $29 from $31
     * Berkshire Hills Bancorp Inc  BHLB.N : Piper Sandler cuts to underweight from neutral
     * BlackRock Inc  BLK.N : JP Morgan cuts target price to $666 from $716
     * Cemex SAB de CV  CX.N : JP Morgan cuts target price to $5.5 from $6
     * Emerson  EMR.N : Oppenheimer cuts target price to $105 from $110
     * Endeavor Group Holdings Inc  EDR.N : Credit Suisse cuts target price to $30 from $33
     * Fastenal Co  FAST.O : Stephens cuts target price to $55 from $60
     * Figs Inc  FIGS.N : Barclays cuts target price to $9 from $15
     * Figs Inc  FIGS.N : Barclays cuts to equal weight from overweight
     * Five9 Inc  FIVN.O : Piper Sandler cuts target price to $77 from $150
     * Infosys Ltd  INFY.N : Jefferies cuts target price to $20.8 from $21.3
     * Lam Research Corp  LRCX.O : Berenberg cuts target price to $470 from $570
     * Membership Collective Group Inc  MCG.N : HSBC cuts target price to $7 from $10.3
     * Origin Materials Inc  ORGN.O : Credit Suisse initiates with outperform rating and $7 PT
     * Owens & Minor Inc  OMI.N : Credit Suisse cuts target price to $20 from $37
     * Relmada Therapeutics Inc  RLMD.O : Oppenheimer cuts to perform from outperform
     * Relmada Therapeutics Inc  RLMD.O : Oppenheimer cuts target price to $7 from $64
     * T2 Biosystems  TTOO.O : Alliance Global Partners adjusts PT to $2.45 from $7 to reflect 1-for-50
 reverse stock split
     * Travere Therapeutics Inc  TVTX.O : Piper Sandler cuts target price to $38 from $39
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))